SCHEMBL17996098

SCHEMBL17996098

CC1(C)c2cc3c4ccccc4c4ccccc4c3cc2-c2cc3c4cc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)ccc4n(-c4ccccc4)c3cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ ATM Q13315 1/20 0.45
▸ PTGER4 P35408 1/20 0.35
▸ TSPO P30536 1/20 0.34
▸ HDAC4 P56524 1/20 0.34
▸ KMT2A Q03164 3/20 0.32
▸ MAPK8 P45983 1/20 0.32
▸ IL1R1 P14778 1/20 0.32
▸ RXRA P19793 1/20 0.31
▸ RXRB P28702 1/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ HTT P42858 2/20 0.31
▸ MAPK1 P28482 2/20 0.31
▸ HPGD P15428 1/20 0.31
▸ HBB P68871 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17996097 0.97 KDM4E (0.45) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL14822267 0.96 KDM4E (0.49) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL15801378 0.94 KDM4E (0.42) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL17886442 0.94 L3MBTL1 (0.44) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL18351605 0.94 KDM4E (0.51) KDM4EL3MBTL1ATMHDAC4KMT2A
SCHEMBL14886393 0.93 KDM4E (0.41) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL16076393 0.93 KDM4E (0.41) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL16076410 0.93 KDM4E (0.43) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL16641279 0.93 KDM4E (0.45) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL15338003 0.93 KDM4E (0.45) KDM4EL3MBTL1ATMPTGER4TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10686146-B2 Paracyclophane-based iridium complexes for organic electroluminescence device UDC IRELAND LIMITED (IE) 2020-06-16 — — US disclosed
US-10636977-B2 Light emitting material for organic electroluminescence device LUMINESCENCE TECHNOLOGY CORP. (TW) 2020-04-28 — — US disclosed
US-10186668-B2 Organic electroluminescent material and use thereof LUMINESCENCE TECHNOLOGY CORP. (TW) 2019-01-22 — — US disclosed
US-9893305-B2 Indenotriphenylene-based iridium complexes for organic electroluminescence device UDC IRELAND LIMITED (IE) 2018-02-13 — — US disclosed
US-9893305-B2 Indenotriphenylene-based iridium complexes for organic electroluminescence device UDC IRELAND LIMITED (IE) 2018-02-13 — — US disclosed
US-20160372679-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENCE DEVICE LUMINESCENCE TECHNOLOGY CORP. (TW) 2016-12-22 — — US disclosed
US-20160372679-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENCE DEVICE LUMINESCENCE TECHNOLOGY CORP. (TW) 2016-12-22 — — US disclosed
US-20160351835-A1 INDENOTRIPHENYLENE-BASED IRIDIUM COMPLEXES FOR ORGANIC ELECTROLUMINESCENCE DEVICE UDC IRELAND LIMITED (IE) 2016-12-01 — — US disclosed
US-20160351835-A1 INDENOTRIPHENYLENE-BASED IRIDIUM COMPLEXES FOR ORGANIC ELECTROLUMINESCENCE DEVICE UDC IRELAND LIMITED (IE) 2016-12-01 — — US disclosed
US-20160233442-A1 IRIDIUM COMPLEXES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION 2016-08-11 — — US disclosed
US-20160233442-A1 IRIDIUM COMPLEXES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION 2016-08-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160351835-A1 INDENOTRIPHENYLENE-BASED IRIDIUM COMPLEXES FOR ORGANIC ELECTROLUMINESCENCE DEVICE CHRM1, IDO1, CCNE2 KDM4E 973/4885L3MBTL1 410/4885ATM 3230/4885
US-20160233442-A1 IRIDIUM COMPLEXES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME H1-0, H1-4, H1-3 KDM4E 1458/4885L3MBTL1 199/4885ATM 4434/4885
US-20160372679-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENCE DEVICE CCNE2, CYP3A4, CCNE1 KDM4E 1289/4885L3MBTL1 114/4885ATM 2012/4885
US-10686146-B2 Paracyclophane-based iridium complexes for organic electroluminescence device CXCL8, CCR8, IPO8 KDM4E 4462/4885L3MBTL1 786/4885ATM 3664/4885
US-10636977-B2 Light emitting material for organic electroluminescence device H1-4, H1-0, CCNE2 KDM4E 799/4885L3MBTL1 82/4885ATM 2481/4885
US-10186668-B2 Organic electroluminescent material and use thereof EPB41, EPB41L2, MORF4L1 KDM4E 857/4885L3MBTL1 64/4885ATM 4316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback